UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 46,395 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 42.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 155,010 shares of the company's stock after buying an additional 46,395 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.10% of Integral Ad Science worth $1,618,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of IAS. Vanguard Group Inc. raised its position in Integral Ad Science by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock valued at $94,467,000 after purchasing an additional 205,562 shares in the last quarter. Alyeska Investment Group L.P. purchased a new stake in Integral Ad Science in the fourth quarter worth approximately $41,543,000. Dimensional Fund Advisors LP grew its position in Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after acquiring an additional 580,323 shares during the last quarter. Ararat Capital Management LP raised its stake in shares of Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after acquiring an additional 269,346 shares in the last quarter. Finally, Nuveen Asset Management LLC lifted its holdings in shares of Integral Ad Science by 0.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock worth $20,050,000 after acquiring an additional 15,432 shares during the last quarter. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

Integral Ad Science Price Performance

NASDAQ IAS remained flat at $8.26 during trading hours on Thursday. The company had a trading volume of 1,130,923 shares, compared to its average volume of 998,323. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62. The stock has a 50 day moving average price of $7.47 and a 200 day moving average price of $9.20. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The company has a market capitalization of $1.36 billion, a P/E ratio of 41.30, a P/E/G ratio of 1.06 and a beta of 1.59.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $134.07 million during the quarter, compared to analysts' expectations of $129.20 million. As a group, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 8,547 shares of the company's stock in a transaction on Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the completion of the sale, the chief executive officer now directly owns 341,271 shares in the company, valued at $2,337,706.35. This represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last three months, insiders have sold 86,222 shares of company stock valued at $636,252. Insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

IAS has been the subject of several analyst reports. Robert W. Baird restated a "neutral" rating and set a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Truist Financial boosted their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a research report on Monday, March 3rd. Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Raymond James boosted their target price on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a report on Tuesday, May 13th. Seven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $13.55.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.